spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Gerresheimer AG and Nelson Labs NV announce strategic alliance regarding Extractables and Leachables lab testing for the Pharmaceutical and Biotech Industries Gerresheimer AG and Nelson Labs NV announce strategic alliance regarding Extractables and Leach

Gerresheimer AG

To accelerate and de-risk drug development, Gerresheimer AG and Nelson Labs NV announce a formal strategic partnership on analytical and drug compatibility lab testing for the Pharmaceutical and Biotech Industries.



Düsseldorf / Leuven, Belgium, October 31, 2022 - Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Nelson Labs, a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries are announcing today the establishment of a strategic partnership to support pharmaceutical and biotech companies in their development of primary packaging systems. The partnership between Gerrensheimer’s Gx Biological Solutions and Nelson Labs leverages the expertise and competencies of two leaders in science and technology to significantly reduce risk and time to market for primary packaging solutions for injectables. Through this collaboration Nelson Labs will conduct extractables & leachables (E&L) testing, toxicological risk assessments, impurity identifications, and biocompatibility testing of injectable primary container closure systems or components.

Piet Christiaens, Scientific Director, Nelson Labs: “I am extremely pleased that Gerresheimer and Nelson Labs have taken this very important step forward in joining our forces to provide customers with stellar testing and expert advice in container/closure qualification. From the initial discussions of the partnership, it was clear that both companies share the same values when it comes to service-oriented customer support. This partnership is designed to help the pharmaceutical industry take full advantage of our scientific leadership, unique Compounds Screener Database, personalized support, and other resources that will be offered through this alliance. This strategic partnership will allow Nelson Labs to further expand our position in the vibrant and rapidly developing Asia Pacific Region.”

Stefan Verheyden, Global VP, Gx Biological Solutions: “Thanks to this partnership with Nelson Labs, and its proven track record in the fields of container closure integrity (CCI) and E&L, we at Gerresheimer have become one of the world's leading partners of the pharmaceutical and healthcare industries. Our broad portfolio includes many pharmaceutical packaging products and safe drug delivery systems such as insulin pens, inhalers, prefilled syringes, vials, cartridges, and bottles and containers for liquid and solid drugs with closure and safety systems. We have been serving the biologics market with our solutions for many years and have recently observed an increasing diversification of the market, its industry leaders, and their requirements. Therefore, we are extremely excited to enter this strategic partnership with Nelson Labs to further expand the support we offer biopharmaceutical companies.”

Jean-Edouard Rabier, Director, Business Development, Gx Biological Solutions: “With this agreement, Gx Biological Solutions will be able to offer an extended service package to our pharmaceutical and biotechnological customers for their new drug development and product life cycle management. We are now able to provide our customers the best selection of primary packaging systems (vials, syringes, and cartridges) made of glass or cyclic olefin polymer (COP) without any concerns about compatibility, stability, or safety of the drug product. Leading-edge scientific expertise, strong market recognition of Nelson Labs is definitely a must for Gx Biological Solutions to reach our objectives to be a scientific destination and a provider of best-in class primary packaging systems, with an end-to-end support to our customers.
phone +49-(0)211/61 81-00
email info@gerresheimer.com
web www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Cherwell publishes new guide to EM best practice in compliance with revised Annex 1

Bicester, UK, 26th January 2023: Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published an update to its guide on “Environmental Monitoring Processes and Validation”, incorporating specific detail on the new version of EU GMP Annex 1. This aims to help sterile medicinal product manufacturers with reviewing and improving their Environmental Monitoring (EM) programs in preparation for compliance with the revised guidelines by August 2023.
More info >>


White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement